Skip to search formSkip to main contentSkip to account menu

IMMUNODEFICIENCY 49

Known as: IMD49, SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES, SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Recreational marijuana (or cannabis) is scheduled to be legalized by the Federal Government of Canada on October 17th, 2018 with… 
Review
2014
Review
2014
The clinical review on managing spasticity in adults is important for both primary and secondary care clinicians.1 Most patients… 
2013
2013
Background: Botulinum toxin type A (BTX-A), one of the most potent biological toxins, acts by blocking neuromuscular transmission… 
2011
2001
2001
The reciprocal muscular activity between the tibialis anterior (TA) and the triceps surae (TS) at a human walking cycle was… 
1982
1982
In connection with two observations of suprasacral complete spinal cord patients showing a clear sublesional spasticity and… 
1975
1975
SEVERAL individuals have been recognised as having an almost complete deficiency of the lysosomal hydrolase α-L-fucosidase (EC 3…